Literature DB >> 25631537

N-Acetylcysteine (NAC)-Induced Hyponatremia Caused by an Electronic Medical Record (EMR) Order Error.

Jakub Furmaga1, Paul Wax, Kurt Kleinschmidt.   

Abstract

INTRODUCTION: Intravenous N-acetylcysteine (NAC) causes few adverse drug events, with mild anaphylactoid reactions being the most common. Hyponatremia as a complication of hypoosmolar NAC solution has been reported. We describe how a locally constructed electronic medical record (EMR) order set for IV NAC resulted in a seizure from hyponatremia due to excess free water administration. CASE REPORT: A 13-month-old female with no past medical history presented to a hospital after ingesting an unknown number of acetaminophen 500 mg tablets. The 4-h acetaminophen concentration was 343 mcg/mL, and she was started on IV NAC. 8.2 h into her 21-h IV NAC protocol, she developed a tonic-clonic seizure. Repeat serum sodium was 124 mEq/L, a decrease from 142 mEq/L at the time of admission. She was treated with hypertonic saline, lorazepam, and levetiracetam and had no further seizures. A brain MRI and EEG were both normal. After the seizure was stabilized, the providers noticed that the patient had receive a total of 900 mL of D5W (112.5 mL/kg) in the first 9 h of hospitalization. This was caused by a poorly constructed, restrictive, EMR order set that did not allow customization of the IV NAC preparation. DISCUSSION: Because the 21-h IV NAC administration involves preparation of 3 different doses infused over 3 different time intervals, an order set was developed to reduce ordering errors. However, error in its construction caused the pharmacist to prepare a solution containing too much free water, decreasing patient's intravascular sodium and resulting in a seizure.
CONCLUSION: The purposes of our case report were to highlight the dangers of overreliance on EMR order sets and to recognize hyponatremic seizures as an adverse reaction of an inappropriately prepared IV NAC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25631537      PMCID: PMC4547965          DOI: 10.1007/s13181-015-0461-4

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  8 in total

1.  Evaluating the capability of information technology to prevent adverse drug events: a computer simulation approach.

Authors:  James G Anderson; Stephen J Jay; Marilyn Anderson; Thaddeus J Hunt
Journal:  J Am Med Inform Assoc       Date:  2002 Sep-Oct       Impact factor: 4.497

2.  Dilution of intravenous N-acetylcysteine as a cause of hyponatremia.

Authors:  L Sung; J A Simons; N L Dayneka
Journal:  Pediatrics       Date:  1997-09       Impact factor: 7.124

3.  A long-term follow-up evaluation of electronic health record prescribing safety.

Authors:  Erika L Abramson; Sameer Malhotra; S Nena Osorio; Alison Edwards; Adam Cheriff; Curtis Cole; Rainu Kaushal
Journal:  J Am Med Inform Assoc       Date:  2013-04-11       Impact factor: 4.497

4.  Evaluation of a simplified N-acetylcysteine dosing regimen for the treatment of acetaminophen toxicity.

Authors:  Michael T Johnson; Craig A McCammon; Michael E Mullins; S Eliza Halcomb
Journal:  Ann Pharmacother       Date:  2011-05-17       Impact factor: 3.154

Review 5.  Adverse reactions associated with acetylcysteine.

Authors:  E A Sandilands; D N Bateman
Journal:  Clin Toxicol (Phila)       Date:  2009-02       Impact factor: 4.467

6.  Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death.

Authors:  Benoit Bailey; René Blais; Anne Letarte
Journal:  Ann Emerg Med       Date:  2004-10       Impact factor: 5.721

7.  Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose.

Authors:  Bryan D Hayes; Wendy Klein-Schwartz; Suzanne Doyon
Journal:  Ann Pharmacother       Date:  2008-04-29       Impact factor: 3.154

8.  Life-threatening hyponatremia due to intravenous n-acetylcysteine treatment in an infant: a case report.

Authors:  Juan Mayordomo-Colunga; Elene Larrea; Mónica García; Sonsoles Suárez; Julián Rodríguez
Journal:  Cases J       Date:  2009-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.